|
据Chemical 3 |, Y3 s- {$ a" i" L. P. V
! G% W8 p5 O% N. Y. Z2 ~; a! b
watch 12月4日发布的消息,关于第二批15个待定的高关注度物质,各成员国已经一致同意将其确定SVHC,ECHA预计这15个物质正式归入SVHC清单的时间约在2010年1月份左右。
; c$ g$ v6 @! e% R! z- X9 i& `) p) F+ m, |: H3 d6 p
$ |$ H* l1 y7 B- q; x5 ]
英文来不及翻译,将就着看吧
7 f. g# A% z+ U( f# qAll substances in latest raft of nominations unanimously accepted8 s$ z6 k; Y+ }+ M/ P4 A
04-Dec-2009
) A; ^2 q [ I: r* \. IYour free trial ends on 18 December
) {# E% k# l5 K
, Z4 {* ~9 T9 i2009. Subscribe Today
( I' d c: _6 t& bThe Member States Committee of the European Chemical Agency (ECHA) has unanimously agreed that a further 15 substances of very high 7 W9 e; F- I I
4 y( x" j" |0 d8 R) Econcern (SVHC) should be included on the REACH Candidate List of substances that may require authorisation under REACH.8 o& {2 s) h1 w+ o/ ?8 }: L& _
The substances include five forms 6 N$ G5 }% E# X( C# T
7 C% K; h" c- v6 Z2 w% F6 P" ? G1 rof the polyaromatic hydrocarbon anthracene, which is used to make rubber products. All are considered to be persistent, bioaccumulative and toxic. The others 0 m9 Q# G* C# r. P- U% e
* X0 h1 ?# M+ R1 [, B
are high temperature coal tar pitch; acrylamide; 2,4-dinitrotoluene; lead chromate molybdate sulphate red; lead sulphochromate yellow; tris(2-chloroethyl)
+ @( a: N: T& d( a) H
$ A& {% [ t9 l) g& V, aphosphate;diisobutyl phthalate; aluminosilicate refractory ceramic fibres; zirconia aluminosilicate refractory fibres and lead chromate. Eight of the ! w% H ]) p1 T: Y
4 j( x& O& t- H, G" Q. S
nominations came from Germany (CW 1 September 2009
- X9 r3 i* O# c# r' LECHA is expected to formally adopt the decision and publish the 15 substances identified as SVHCs on ! g$ E* m9 N/ D4 d1 T- `3 s
. E/ Y: O5 o8 z. g7 g
the Candidate List in January, bringing the total on the list to 30. This will trigger the right of consumers to ask for information about their inclusion in
; G+ |; e* T5 Q9 ~5 \3 Y* z& b4 [; s
4 t E. A# A, ?5 `% m- Tproducts, with a right of reply within 45 days.
* A# m9 F- |% I! qThe Agency is expected to recommend which of the substances should be prioritised for authorisation, and
' M9 S/ U5 G' s- K5 Y; G+ W6 E3 u* ]; M, \$ L) F7 H7 e
thus included in Annex XIV, sometime in the second half of next year.1 T0 Q/ L' C& L; j% {( \/ N; ?
The committee also discussed ECHA's progress in refining its approach to the
0 _2 H' g- [" U: r: P7 u
3 e3 P; K2 r2 t8 N% Jprioritisation of SVHCs for inclusion in Annex XIV. Its approach is based on legal requirements set out in Article 58(3) of REACH, which defines three main 4 i) F3 y5 S/ C$ w$ L# [/ Z% ]! Y
8 s9 C# m& `9 d' Z' K _& a+ G
prioritisation criteria – being produced in high volumes; or exhibiting persistent, bioaccumulative and toxic (PBT) properties or very persistent, very ) E; V' u3 u& { f
R$ q4 t* l# f h7 \" [" D" k
bioaccumulative (vPvB) properties; or having wide dispersive use.& ~$ p2 f0 p& r, q) n) o; N7 S
According to ECHA's guidance on its general approach to prioritisation, issued in June, 8 D$ C4 [1 Q/ }8 F
( q) O: q$ m) u0 w4 W
the three “are assessed together in a weight of evidence approach in a qualitative, where possible semi-quantitative manner, resulting in an overall
7 z% Z* t5 s! F. ?
# j3 ]& ^4 b% Iconclusion on the priority of the substance. The number of criteria met and the extent to which the criteria are fulfilled (i.e. the higher the rating of the 0 m0 i8 Z( p' e {5 s0 @: k- h
. o- d* x4 P& l* j( w* Z
intrinsic properties, the more wide dispersive the uses and the higher the volumes not exempted from authorisation) are important factors in deciding whether
/ T1 a. [ j5 O8 Z5 ]( w% j9 T- | G: O
or not to prioritise a substance.”' f' f/ I5 _' }, L& D1 v
The committee supported ECHA's proposals but decided there are some small details that can be improved. One example
. S) o/ l* V8 m
/ c. {$ ^3 t) b7 y5 }, \& t! K0 S, fwould be to introduce a scoring system for information that is available, such as volume, with a substance's score varying according to its production . t& {8 n- ?! ]# S
/ j5 B M2 @1 E( zvolume. This would help to make ECHA's decisions more transparent. The Agency's proposals will be re-examined at the committee's next meeting on 27-28 + a: L& U t; V7 d9 T& u
4 r/ `* V% m$ ^6 R. k8 wApril.) N+ K V$ ^$ r! ^
The committee also discussed its first draft decision from the Agency on a REACH registrant's testing proposal, and accepted it unanimously.
. H/ a, x3 g3 [: m
/ T* D8 H9 `2 IDetails concerning the substance and registrant involved are confidential. The committee expects to receive further Agency draft decisions relating to
( t8 X& z4 F9 @* D% }, v% Y9 L2 X* r# T7 K) m
dossier compliance checks and testing proposals in the spring. |
|